Non-replication of association between cathepsin D genotype and late onset alzheimer disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 105, Issue 2, 2001, Pages 179-182

  Menzer, Gunnar ^a   Müller Thomsen, Tomas ^a   Meins, Wolfgang ^a   Alberici, Antonella ^b   Binetti, Giuliano ^a   Hock, Christoph ^d   Nitsch, Roger M ^b   Stoppe, Gabriela ^c   Reiss, Jochen ^e   Finckh, Ulrich ^a,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ALBERTINEN KRANKENHAUS   (Germany)

^c Scientific Institute for Research and Patient Care   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

APOE; Cat D; CTSD; Interactions

Indexed keywords

CATHEPSIN D;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGE FACTORS; AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; CATHEPSIN D; FEMALE; GENOTYPE; GERMANY; HETEROZYGOTE; HUMANS; ITALY; MALE; MODELS, STATISTICAL; ODDS RATIO; POLYMORPHISM, GENETIC; SEX FACTORS; SWITZERLAND;

FELIS CATUS;

EID: 0035825982     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.1204     Document Type: Article

References (20)

1. Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type
2. Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease
3. Increased secretion, altered processing, and glycosylation of procathepsin D in human mammary cancer cells
4. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system
5. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased-amyloidogenesis
6. Cathepsin D displays in vitro β-secretase-like specifity
7. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
8. The genetic association between cathepsin D and Alzheimer's disease
9. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis
10. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
11. Degradation of Tau by lysosomal enzyme cathepsin D: Implication for Alzheimer neurofibrillary degeneration
12. Degradation of Alzheimer's β-amyloid protein by human cathepsin D
13. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease
14. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
15. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease
16. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease
17. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women
18. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D
19. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease
20. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction - Single strand conformational polymorphism analysis and possible consequences in cancer cells